期刊文献+

肾细胞癌基质金属蛋白酶-9与血管生成的关系 被引量:3

Relationship between MMP-9 and angiogenesis in renal cell cacinoma
暂未订购
导出
摘要 目的 观察基质金属蛋白酶-9(matrix metalloproteinase-9,MMP-9)在肾细胞癌组织中的表达特点及其与微血管密度(microvessel density,MVD)的关系,探讨MMP-9对肾细胞癌血管生成的作用和意义。方法 采用SP免疫组织化学染色方法检测55例肾细胞癌组织中MMP-9和CD34的表达,并结合临床病理参数进行综合分析。结果 MMP-9蛋白在肾细胞癌组织中的阳性率为63.63%。肾癌组织中MMP-9的表达显著高于正常肾组织(P<0.05),且与肿瘤中MVD密切正相关(r=0.456,P<0.01)。MMP-9的表达和肿瘤中MVD均与肾癌的分期、肾包膜侵袭和淋巴结转移密切相关(P<0.05),而与肾癌组织学类型无关(P>0.05)。结论 肾癌组织MMP-9高表达与MVD及肾癌的一些生物学行为、转移发生有密切关系,MMP-9可能是肾癌的重要促血管生成因子之一。 Objective To explore the role and the significance of matrix metalloproteinase-9 (MMP-9) on angiogenesis in renal cell carcinoma (RCC) through observing the relationship between the expression of MMP-9 and microvessel density (MVD) in RCC. Methods The expression of MMP-9 and CD34 in RCCs specimens were detected by immunohistochemical technique, and the clinical pathological pa- rameters were analyzed at the same time. Results The positive rate of MMP-9 was 63.63% in RCC tissue. The expression of MMP-9 in RCC tissue, being significantly correlated with MVD in tumor (r= 0.456, P<0.01), was remarkably higher than that in normal renal tissue ( P < 0.05). MMP-9 expression and MVD in tumor were closely related ID clinical stage, renal fibromembrane invasion and lymph node metastasis (P<0.05), but not related to pathological types of RCC (P>0.05). The higher the tumor stage, the higher the expression of MMP-9 and MVD, MMP-9 and MVD's expression were significantly higher in invasion and metastasis than in no invasion and metastasis. Conclusion The high expression of MMP-9 was significantly associated with MVD, biological behaviors of RCC, MMP-9 might be one of the important factors in the angiogenesis of RCC.
出处 《实用肿瘤学杂志》 CAS 2003年第1期12-15,共4页 Practical Oncology Journal
关键词 肾细胞癌 基质金属蛋白酶-9 血管生成 免疫组织化学 Kidney neoplasms Carcinoma Matrix metalloproteinase-9 Immunohistochemistly
  • 相关文献

参考文献8

  • 1Cornelius LA, Nehring LC, Roby JD, et al. Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration. J Invest Dermatol, 1995; 105 (2): 170~176
  • 2Kleiner DE, Stetler-Stevenson WG. Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol, 1999;43 (supp1): 542 ~ 47
  • 3Ozdemir E, Kakehi Y, Okuno H, et al. Role of matrix metalloproteinase-9 in the basenent membrane destruction of superficial urothelial carcinomas. J Urol, 1999;161(4):1359~ 1363
  • 4黄文斌,杜少陵,徐国祥,齐琼,林鸿民.胃癌组织中p27^(KIP1)和MMP-9的表达及其临床意义[J].临床与实验病理学杂志,2002,18(2):171-174. 被引量:8
  • 5许璟,刘伟国,杨小锋,林敏.MMP-2、MMP-9、TIMP-1在星形细胞瘤中的表达及其意义[J].中华实验外科杂志,2002,19(3):245-246. 被引量:14
  • 6Slaton JW, Inoue K, Perrotte P, et al. Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renel cell carcinoma. Am J Pathol, 2001; 158 ( 2 ): 735 ~ 743
  • 7Folkman J. Tumorangiogenesis. In:Anderson J Howley P eds. Molecular Basis of Cancer. Philadephia and Pensyluania:WB Sounders Pub, 1995;206~225
  • 8Stearns ME, Rhim J, Wang M. Interleukin 10 (IL-10) inhibiton of primary human prostate cell-induced angiogenesis: IL-10 stimulation of tissuef inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinas (MMP-2)/MMP-9 seeretion. Clin Cancer Res, 1999; (5): 189 ~ 196

二级参考文献5

  • 1Sawaya RE,Yamamoto M,Gokaslan ZL,et al.Expression and cocalization of 72Kda typeⅣcollagenase(MMP-2)in human malignant gliomas in vivo.Clin Exp Metastasis,1996,14:35-42.
  • 2Rao JS,Yamamoto M,Mohaman S,et al.Expression and localization of 92Kda typeⅣcollagenase/gelatinase B(MMP-9)in human gliomas.Clin Exp Metastasis,1996,14:12-18.
  • 3Cawston TE,Galloway WA,Mercer E,et al.Purification of rabbit bone inhibitor of collagenase.Biochem J,1981,195:159-165.
  • 4Lampert K,Machein U,Mchein M.et al.Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors.AmJPathol,1998,153:429-437.
  • 5王福生,蒋丹斌,宋怀宇,荆梦杰,苏媛,张廷国.p27^(kip1)在胃癌中的表达及与临床病理分期和预后的关系[J].临床与实验病理学杂志,2000,16(6):487-488. 被引量:4

共引文献20

同被引文献51

  • 1蒋荣珍,陈汉平.核因子κB在妊高征患者胎盘组织的定位及定量研究[J].中国优生与遗传杂志,2004,12(3):47-48. 被引量:5
  • 2康德凡,尚丽新,曲冬颖,姜彦多,王继红.妊娠高血压综合征患者胎盘组织中TGFβ1的表达及意义[J].中国医师杂志,2004,6(7):889-891. 被引量:2
  • 3詹瑛,陈维萍,叶元华,楼艳辉.妊娠高血压患者胎盘组织基质金属蛋白酶-9与肿瘤坏死因子-α的表达[J].第一军医大学学报,2005,25(8):1070-1071. 被引量:14
  • 4Ohashi K, Nemoto T, Nakamura K, et aL Increased expression of matrix metalloproteinase7 and 9 and membrane typel-matrix metalloproteinase in esophageal squamous cell carcinomas. Cancer,2000,88(10):2201-2209.
  • 5Morgan AR,Zhang B,Tapper W,et al. Haplotypic analysis of the MMP9 gene in relation to coronary artery disease. J Mol Med,2003,81(5):321-326.
  • 6Joos L, He JQ,Megan B,et al. The role of matrix metaloproteinase polymorphisrns in the rate of decline in lung function. Hum Mol Genet,2002,11(5):569-576.
  • 7Kerkela E,Ala-Aho R, Jeskanen L,et al. Expression of human macrophage metalloelastase (MMP12) by tumor colls in skin cancer. J Invest Dermatol,2000,114(6):1113-1119.
  • 8Ding Y, Shimada Y, Gorrin-Rivas MJ, et al. Clinicopathological significanco of human macrophage metalloelsstase expression in esophageal squamous cell carcinoma. Oncology,2002,63 (4):378-384.
  • 9Szyllo K,Smolarz B,Romanowicz-Makowska H,et al. The promoter polymorphism of the matrix metalloproteinase3 (MMP3)gene in women with ovarian cancer. Exp Clin Cancer Res, 2002,21 (3):357-361.
  • 10Liu PY,Chen JH,Li YH,et al. Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction. Thromb Haemost,2003,90(1):132-139.

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部